A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer | |
Guo Xiao-Fang; Zhu Xiao-Fei; Cao Hai-Ying; Zhong Gen-Shen; Li Liang; Deng Bao-Guo; Chen Ping; Wang Pei-Zhen; Miao Qing-Fang; Zhen Yong-Su | |
2017 | |
卷号 | 8期号:16页码:27286-27299 |
关键词 | EGFR IGF-1R lidamycin bispecific fusion protein NSCLC |
ISSN号 | 1949-2553 |
DOI | 10.18632/oncotarget.15933 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367246 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Guo Xiao-Fang,Zhu Xiao-Fei,Cao Hai-Ying,et al. A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer[J],2017,8(16):27286-27299. |
APA | Guo Xiao-Fang.,Zhu Xiao-Fei.,Cao Hai-Ying.,Zhong Gen-Shen.,Li Liang.,...&Zhen Yong-Su.(2017).A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer.,8(16),27286-27299. |
MLA | Guo Xiao-Fang,et al."A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer".8.16(2017):27286-27299. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论